ArticlePloS one2026
Shared genetic architecture of HCM and AF: Elevated NPPA/ANP is linked to atrial electrical remodeling.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertrophic cardiomyopathy (HCM) patients exhibit heightened susceptibility to atrial fibrillation (AF), yet the underlying genetic nexus remains poorly defined. This study aimed to identify genes common to HCM and AF, thereby revealing the underlying pathogenesis of susceptibility to AF in HCM patients.
methodsGenes associated with HCM and AF were sourced from the Gene Expression Omnibus (GEO), Online Mendelian Inheritance in Man (OMIM), Comparative Toxicogenomics Database (CTD), GeneCards, and DisGeNET databases. We conducted a comparative analysis to identify overlapping genes between HCM and AF for further investigation, which included functional enrichment analysis, protein-protein interaction networks, and immune infiltration assessment. Key hub genes were determined using cytoHubba, a Cytoscape plugin, and their validation was performed using independent datasets GSE36961 and GSE115574. The genes corroborated by these datasets were additionally validated in clinical samples.
resultsA total of 11 overlapping genes were identified between HCM and AF. Functional enrichment and immune infiltration analyses revealed their involvement in immune regulation and inflammatory processes. Three hub genes NPPA, ACE, and POMC were recognized as key molecular links between HCM and AF. Validation using the GSE36961 dataset confirmed the upregulation of NPPA in HCM, supporting its potential as a central gene connecting the two conditions. Consistent with the bioinformatics findings, exploratory clinical verification findings of serum levels of N-terminal fragment of A-type natriuretic peptide (NT-proANP), encoded by NPPA, were markedly elevated in both the HCM and HCM with AF groups compared with healthy controls (P < 0.01). Moreover, NT-proANP concentrations were significantly higher in the HCM + AF group than in the HCM-only group (P < 0.01).
conclusionThis study identifies a shared genetic link between HCM and AF. The findings strongly associate elevated NT-proANP levels, encoded by the NPPA gene, with AF in HCM patients. We propose NT-proANP as a promising circulating biomarker for stratifying AF risk in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.